There are about 153 western medicines producing enterprises, 80 traditional medicines producing enterprises, and over 300 establishments producing traditional medicines in 2015. Vietnam’s pharmaceutical sector uses about 60,000 tons of pharmaceuticals, including 80-90% of imported pharmaceuticals. The growth of the prescription drug market will exceed the growth rate of Over-the-counter (OTC) market. According to Drug Administration of Vietnam – Ministry of Health, from the beginning of the year to 6/15/2018: Regarding imported drugs, there are 468 drug items declared price, 14 items re-declared price; for produced medicines, 900 items declared price, 88 items re-declared price. The biggest wholesale market systems in Vietnam pharmaceutical distribution in Ho Chi Minh City and Hanoi. Pharmaceutical products are necessities, thus, economic growth virtually has hardly any impact on the industry growth rate. For the WTO, the Vietnamese pharmaceutical market has gradually opened. M&A trend between domestic and foreign enterprises takes place strongly in the form of franchise drug production and the field of distribution. Most of the enterprises of pharmaceutical industry maintained positive operation with high levels of gross profit and net profit in the period 2016-2017.

0/5 (0 Reviews)
0/5 (0 Reviews)
 Executive Summary
1. Business environment
1.1 Macroeconomic situation
1.2 Legal framework
2. Pharmaceutical Industry Overview
2.1 Global Pharmaceutical Industry
2.1.1 Production – Consumption
2.2 Vietnam Pharmaceutical Industry Overview
2.2.1 History of Vietnam Pharmaceutical Industry
2.2.2 Industry Position
2.2.3 Industry Scale and Feature
2.2.4 Value Chain of Vietnam Pharmaceutical Industry
2.2.5 Production
2.2.6 Consumption
2.2.7 Export – Import
2.2.8 Price movement
2.3 Industry planning
2.4 Driving forces for industry development
3. Enterprise analysis
3.1 Profitability
3.2 Cost structure
3.3 Asset Management Ratios
3.4 Capital Structure
3.5 Solvency
3.6 Return on Investment

0/5 (0 Reviews)
0/5 (0 Reviews)
DHG Pharmaceutical Joint Stock Company
TRAPHACO Joint Stock Company
Domesco Medical Import-Export JSC
Imexpharm Pharmaceutical JSC
OPC Pharmaceutical JSC
S.P.M JSC
Vimedimex Medi – Pharma JSC
Ha Tay Pharmaceutical JSC
Ben Tre Pharmaceutical JSC
Lam Dong Pharmaceutical JSC

0/5 (0 Reviews)
0/5 (0 Reviews)
List of figures
Figure 1: GDP growth, 2011 – 6M/2018
Figure 2: Consumer Price Index for Medicines and Health Services, 2012 – 6M/2018
Figure 3: VND/USD exchange rate, 6/2016 – 6/2018
Figure 4: VND/CNY exchange rate, 1/2016 – 6/2018
Figure 5: Population structure, 1999 – 2017
Figure 6: Population and population growth, 2006 -2017
Figure 7: The number of new drugs authorized by the FDA, 2010 – 2017
Figure 8: Investment in R&D in the world, 2010 – 2024f
Figure 9: Top 10 enterprises with the largest R & D costs, 2017
Figure 10: Top 10 enterprises with the largest R & D costs, 2024
Figure 11: Revenue of the global pharmaceutical industry, 2010 – 2017e
Figure 12: Worldwide prescription drug sales, 2010 – 2017
Figure 13: Worldwide Drug Sales by Technology, 2010 – 2017
Figure 14: Drug consumption by types, 2011 – 2016
Figure 15: Drug consumption by group, 2017
Figure 16: Top 10 therapeutic classes by estimated global pharmaceutical sales*, 2017
Figure 17: Domestic pharmaceutical production value, 2010 – 2017e
Figure 18: Pharmaceutical market value, 2010 – 2017e
Figure 19: Value ratio of domestically produced medicines in Vietnam, 2010 – 2017e
Figure 20: Domestically produced medicine consumption, 2010 – 6M/2018e
Figure 21: Spending on medicines in Vietnam, 2009 – 2017e
Figure 22: Spending on medicines per capita in some countries, 2016e
Figure 23: Medicines consumption structure by channel, 2010 – 2017e
Figure 24: Current status of Patented and Generic drugs, 2010 – 2017e
Figure 25: Market value of prescription drugs (ETC), 2011 – 2017e
Figure 26: Market value of non-presciption drugs (OTC), 2010 – 2017e
Figure 27: Patened drugs (Patent), 2010 – 2017e
Figure 28: Generic drug market, 2010 – 2017e
Figure 29: Pharmaceutical imports, 2012 – 6M/2018e
Figure 30: Pharmaceutical imports, 6M/2017 – 6M/2018e
Figure 31: Pharmaceuticals imports from India, 2013 – 6M/2018
Figure 32: Top importing enterprises *, 6M/2018
Figure 33: Pharmaceutical exports, 2012 – 6M/2018
Figure 34: Export structure by country, 6M/2018
Figure 35: Total healthcare expenses, 2010 – 2016f
Figure 36: Population tower, 2016
Figure 37: Over-60 population growth in the world, 1950 – 2050
Figure 38: M&A of pharmaceutical industry, 2010 – 2016
Figure 39: The growth of total drug consumption and average drug spending per capita, 2010-2020f
Figure 40: Profitability, 2016 – 2017
Figure 41: COGS/NR, 2016 – 2017
Figure 42: Selling expenses, 2016 – 2017
Figure 43: Administrative expenses, 2016 – 2017
Figure 44: Days in inventory, 2016 – 2017
Figure 45: Days of sales outstanding, 2016 -2017
Figure 46: Asset turnover
Figure 47: Self-financing ratio, 2016 – 2017
Figure 48: Solvency, 2016 – 2017
Figure 49: Profit ratio, 2016 – 2017

List of tables
Table 1: Top pharmaceutical exporting countries, 2017
Table 2: Vietnam’s top import partners, 6M/2018
Table 3: Top exporting enterprises, 6M/2018
Table 4: The difference in the price of some drugs at some drug stores, 2017
Table 5: The number of medical facilities, 2010 – 2016
Table 6: 10 typical pharmaceutical enterprises in 2017

0/5 (0 Reviews)
0/5 (0 Reviews)